 Safety immunogenicity multiple conventional immunizations early HIV infection asymptomatic adults multiple polysaccharide live viral protein-derived vaccines human immunodeficiency virus HIV mean subject age years male mean count mean ratio Serologic responses immunization meningococcus group adenovirus types tetanus diphtheria HIV seropositive subjects responses age- sex- race-matched HIV-seronegative controls HIV antibody antibody vaccines normals HIV-infected subjects functional antibody comparable normals Booster responses HIV subjects diphtheria comparable normals HIV-infected vaccine nonresponders HIV-infected responders total white blood cell total serum IgG delayed-type hypersensitivity skin test reactivity HIV subjects negative cultures live vaccine viruses rubella measles adenovirus poliovirus Postimmunization apparent adverse reactions vaccination